Skip to main content

Taysha Gene Therapies, Inc 8-K, filed Nov 12, 2026

Taysha Gene Therapies, Inc. (TSHA)

8-K 2026-11-12 For: 2026-11-12
View Original
Added on November 12, 2026

About this 8-K

Taysha Gene Therapies, Inc filed this 8-K on November 12, 2026.

Taysha Gene Therapies completed TSHA-102’s BLA-enabling PPQ campaign, meeting predefined specifications and comparability criteria; topline data from the REVEAL pivotal 6-month interim analysis and FDA feedback on the BLA submission pathway are expected in the first half of 2027. AI summary

Items reported

  • Item 2.02: Financial results
  • Item 9.01: Financial statements and exhibits